Description

Spiro[3H-Indole-3,4′-Piperidine]-1′-Carboxylic Acid, 1,2-Dihydro-6-Hydroxy-2-Oxo… is a high-purity, advanced pharmaceutical intermediate characterized by its complex spirocyclic indole-piperidine scaffold. This compound matters as a critical building block in modern medicinal chemistry, enabling the synthesis of novel drug candidates with targeted biological activity. It is primarily needed by R&D teams and production units in the pharmaceutical and biotechnology sectors for developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel small-molecule drug candidates targeting central nervous system (CNS) disorders.
• Medicinal Chemistry Research: Used as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• API Development: Serves as a critical building block in the development and scale-up of Active Pharmaceutical Ingredients (APIs) with complex molecular architectures.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting pharmaceutical companies with custom synthesis and process development.
• Academic Research: Utilized in university and institutional labs for studying heterocyclic chemistry and developing new synthetic methodologies.

Basic Information

Product Name	Spiro[3H-Indole-3,4′-Piperidine]-1′-Carboxylic Acid, 1,2-Dihydro-6-Hydroxy-2-Oxo…
CAS No.	2383903-89-5
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	1,2-Dihydro-6-hydroxy-2-oxospiro[3H-indole-3,4'-piperidine]-1'-carboxylic acid; Spiro[indole-3,4'-piperidine]-1'-carboxylic acid derivative; CAS 2383903-89-5; 6-Hydroxyspiro[indole-3,4'-piperidine]-2,1'-dione derivative; Advanced indole-piperidine spirocycle intermediate
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. Each batch is characterized using advanced analytical techniques to confirm identity, purity, and consistency. Certificates of Analysis (COA) documenting full specifications are available upon request. Our quality system is designed to support cGMP requirements for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Individual impurity ≤ 0.5%
Total Impurities	≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.